2025 annual financial data
InMed Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was -160.2%.
Operating income was -7,917,995 USD and net income was -8,162,133 USD.
Operating cash flow was -7,766,951 USD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,942,633 USD
- Operating income
- -7,917,995 USD
- Net income
- -8,162,133 USD
- Operating cash flow
- -7,766,951 USD